XOMA Corporation (XOMAP) Financial Ratios
30 years of historical data (1996–2025) · Healthcare · Biotechnology
EV/EBITDA
↑
24.70
-1% vs avg
5yr avg: 25.01
30Y Low13.0·High37.0
P/FCF
106.58
↓-37% vs avg
5yr avg: 168.30
30Y Low32.4·High168.3
P/B Ratio
↑
4.38
↑+35% vs avg
5yr avg: 3.23
30Y Low2.3·High4.6
ROE
↑
34.1%
↓+975% vs avg
5yr avg: -3.9%
30Y Low-390%·High252%
Debt/EBITDA
↑
9.16
↑+100% vs avg
5yr avg: 4.59
30Y Low0.0·High12.1
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
XOMAP Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
XOMA Corporation trades at 17.3x earnings, 41% below its 5-year average of 29.4x, sitting at the 0th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a discount of 22%. On a free-cash-flow basis, the stock trades at 106.6x P/FCF, 37% below the 5-year average of 168.3x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $306M | $483M | $303M | $291M | $283M | $321M | $287M | — | — | — | — |
| Enterprise Value | $355M | $532M | $320M | $263M | $225M | $228M | $224M | — | — | — | — |
| P/E Ratio → | 17.35 | 18.40 | — | — | — | 40.46 | 32.04 | — | — | — | — |
| P/S Ratio | 5.87 | 9.27 | 10.63 | 61.26 | 46.96 | 8.40 | 9.78 | — | — | — | — |
| P/B Ratio | 4.38 | 4.65 | 3.70 | 3.29 | 2.28 | 2.26 | 3.33 | — | — | — | — |
| P/FCF | 106.58 | 168.30 | — | — | — | — | 32.36 | — | — | — | — |
| P/OCF | 106.58 | 168.30 | — | — | — | 14.14 | 28.48 | — | — | — | — |
P/E links to full P/E history page with 30-year chart
XOMAP EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
XOMA Corporation's enterprise value stands at 24.7x EBITDA, roughly in line with its 5-year average of 25.0x. The Healthcare sector median is 14.4x, placing the stock at a 72% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 10.20 | 11.25 | 55.20 | 37.37 | 5.96 | 7.64 | — | — | — | — |
| EV / EBITDA | 24.70 | 37.05 | — | — | — | 12.98 | 17.83 | — | — | — | — |
| EV / EBIT | 31.15 | 46.72 | — | — | — | 12.98 | 16.46 | — | — | — | — |
| EV / FCF | — | 185.24 | — | — | — | — | 25.27 | — | — | — | — |
XOMAP Profitability
Margins and return-on-capital ratios measuring operating efficiency
XOMA Corporation earns an operating margin of 21.8%. Operating margins have expanded from -879.5% to 21.8% over the past 3 years, signaling improving operational efficiency. Return on equity of 34.1% is exceptionally high. ROIC of 6.8% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 94.3% | 94.3% | 99.3% | 97.0% | 95.5% | 99.6% | 99.4% | 93.2% | 68.3% | 85.1% | 74.8% |
| Operating Margin | 21.8% | 21.8% | -140.3% | -879.5% | -288.9% | 45.9% | 42.3% | -21.1% | -318.1% | 32.3% | -1106.4% |
| Net Profit Margin | 60.8% | 60.8% | -48.5% | -858.2% | -283.8% | 41.4% | 45.3% | -10.8% | -251.8% | 27.7% | -962.1% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 34.1% | 34.1% | -16.2% | -38.4% | -12.9% | 13.8% | 20.4% | -6.3% | -108.6% | 252.3% | — |
| ROA | 12.8% | 12.8% | -6.1% | -21.8% | -11.1% | 10.8% | 12.0% | -2.5% | -24.5% | 39.7% | -103.4% |
| ROIC | 6.8% | 6.8% | -37.6% | -49.8% | -22.7% | 36.4% | 42.7% | -37.3% | — | — | — |
| ROCE | 5.2% | 5.2% | -19.4% | -24.0% | -12.1% | 13.2% | 12.4% | -5.4% | -35.3% | 101.1% | -257.8% |
XOMAP Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
XOMA Corporation carries a Debt/EBITDA ratio of 9.2x, which is highly leveraged (179% above the sector average of 3.3x). Net debt stands at $49M ($132M total debt minus $83M cash). Interest coverage of just 0.9x is concerning — the company has limited headroom to absorb earnings volatility before struggling with debt service.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.27 | 1.27 | 1.46 | 1.40 | 0.00 | 0.00 | 0.25 | 0.75 | 1.20 | 2.52 | — |
| Debt / EBITDA | 9.16 | 9.16 | — | — | — | 0.01 | 1.69 | — | — | 0.84 | — |
| Net Debt / Equity | — | 0.47 | 0.21 | -0.33 | -0.47 | -0.66 | -0.73 | -0.54 | -1.24 | -4.99 | — |
| Net Debt / EBITDA | 3.39 | 3.39 | — | — | — | -5.31 | -5.00 | — | — | -1.67 | — |
| Debt / FCF | — | 16.94 | — | — | — | — | -7.09 | — | — | -10.79 | — |
| Interest Coverage | 0.87 | 0.87 | -0.41 | -41.24 | — | 38.02 | 7.40 | -0.03 | -13.62 | 14.13 | -12.57 |
XOMAP Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
XOMA Corporation's current ratio of 3.37x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 8.68x to 3.37x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.37 | 3.37 | 5.15 | 8.68 | 8.98 | 7.48 | 7.16 | 6.76 | 8.35 | 5.95 | 0.84 |
| Quick Ratio | 3.37 | 3.37 | 5.15 | 8.68 | 8.98 | 7.48 | 7.03 | 6.76 | 8.35 | 5.95 | 0.84 |
| Cash Ratio | 2.39 | 2.39 | 4.32 | 7.87 | 8.53 | 7.26 | 6.85 | 6.39 | 8.03 | 5.86 | 0.79 |
| Asset Turnover | — | 0.19 | 0.13 | 0.02 | 0.04 | 0.23 | 0.23 | 0.19 | 0.08 | 1.17 | 0.19 |
| Inventory Turnover | — | — | — | — | — | — | 0.11 | — | — | — | — |
| Days Sales Outstanding | — | 34.27 | 218.01 | 1167.49 | 143.35 | 2.00 | 22.22 | 58.28 | 101.12 | 2.75 | 37.13 |
XOMAP Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
XOMA Corporation returns 6.4% to shareholders annually — split between a 1.2% dividend yield and 5.2% buyback yield. The earnings yield of 5.8% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.2% | 1.1% | 1.8% | 1.9% | 1.9% | 1.1% | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 5.8% | 5.4% | — | — | — | 2.5% | 3.1% | — | — | — | — |
| FCF Yield | 0.9% | 0.6% | — | — | — | — | 3.1% | — | — | — | — |
| Buyback Yield | 5.2% | 3.3% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | — | — | — | — |
| Total Shareholder Yield | 6.4% | 4.5% | 1.8% | 1.9% | 1.9% | 1.1% | 0.0% | — | — | — | — |
| Shares Outstanding | — | $18M | $12M | $11M | $11M | $12M | $12M | $9M | $11M | $11M | $11M |
Peer Comparison
Compare XOMAP with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 XOMAPYou | $306M | 17.3 | 24.7 | 106.6 | 94.3% | 21.8% | 34.1% | 6.8% | 9.2 |
 BCYC | $339M | -1.5 | — | — | 100.0% | -341.3% | -31.2% | — | — |
 PRTC | $41M | -0.4 | — | — | 100.0% | -2114.7% | -30.8% | -66.9% | — |
 NUVB | $2B | -8.0 | — | — | 86.6% | -338.7% | -53.2% | -54.3% | — |
 RCUS | $2B | -7.5 | — | — | 96.0% | -156.3% | -63.3% | -64.1% | — |
 PRAX | $10B | -24.7 | — | — | — | — | -45.8% | -65.0% | — |
 ANAB | $3B | -145.6 | 52.9 | 147.2 | 99.0% | 20.4% | -24.5% | 55.1% | 0.3 |
 IMVT | $6B | -10.0 | — | — | — | — | -62.5% | — | — |
 ABBV | $358B | 85.5 | 15.0 | 20.1 | 70.2% | 32.8% | 6214.7% | 23.9% | 2.4 |
 PFE | $151B | 19.5 | 10.7 | 16.6 | 70.3% | 24.7% | 8.9% | 7.5% | 3.3 |
 MRK | $277B | 15.4 | 10.7 | 22.4 | 72.0% | 36.2% | 36.9% | 22.0% | 1.7 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
See XOMAP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XOMAP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare XOMAP vs BCYC
Side-by-side business, growth, and profitability comparison vs Bicycle Therapeutics plc.
Start ComparisonXOMAP — Frequently Asked Questions
Quick answers to the most common questions about buying XOMAP stock.
What is XOMA Corporation's P/E ratio?
XOMA Corporation's current P/E ratio is 17.3x. The historical average is 30.3x.
What is XOMA Corporation's EV/EBITDA?
XOMA Corporation's current EV/EBITDA is 24.7x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 22.6x.
What is XOMA Corporation's ROE?
XOMA Corporation's return on equity (ROE) is 34.1%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is -89.1%.
Is XOMAP stock overvalued?
Based on historical data, XOMA Corporation is trading at a P/E of 17.3x. Compare with industry peers and growth rates for a complete picture.
What is XOMA Corporation's dividend yield?
XOMA Corporation's current dividend yield is 1.20%.
What are XOMA Corporation's profit margins?
XOMA Corporation has 94.3% gross margin and 21.8% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
How much debt does XOMA Corporation have?
XOMA Corporation's Debt/EBITDA ratio is 9.2x, indicating high leverage. A ratio above 4x may signal elevated financial risk.